Gerrit Dispersyn's most recent trade in Phio Pharmaceuticals Corp was a trade of 8,954 Common stock, $0.0001 par value done at an average price of $0.8 . Disclosure was reported to the exchange on March 1, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Phio Pharmaceuticals Corp | Gerrit Dispersyn | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.82 per share. | 01 Mar 2022 | 8,954 | 212,327 (11%) | 0% | 0.8 | 7,351 | Common stock, $0.0001 par value |
Phio Pharmaceuticals Corp | Gerrit Dispersyn | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 126,000 | 221,281 (11%) | 6% | 0 | Common stock, $0.0001 par value | |
Phio Pharmaceuticals Corp | Gerrit Dispersyn | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.56 per share. | 04 Mar 2021 | 1,953 | 89,281 (4%) | 0% | 2.6 | 5,000 | Common stock, $0.0001 par value |
Phio Pharmaceuticals Corp | Gerrit Dispersyn | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 68,450 | 84,828 (4%) | 3% | 0 | Common stock, $0.0001 par value | |
Phio Pharmaceuticals Corp | Gerrit Dispersyn | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 3.03 per share. | 01 Mar 2021 | 2,500 | 87,328 (4%) | 0% | 3.0 | 7,575 | Common stock, $0.0001 par value |
Phio Pharmaceuticals Corp | Gerrit Dispersyn | President & CEO | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 19 Aug 2020 | 2,000 | 16,377 (0%) | 0% | 2.5 | 5,000 | Common stock, $0.0001 par value |